NASDAQ: PCSA

Analyst Snapshot

What is PCSA’s price-to-sales ratio telling us about the company’s value?

Arcelia Reed

Currently, Processa Pharmaceuticals Inc’s (PCSA) stock is trading at $7.6, marking a gain of 152.91% from last night’s close. At ...

Analyst Snapshot

What is PCSA’s price-to-sales ratio telling us about the company’s value?

Arcelia Reed

Currently, Processa Pharmaceuticals Inc’s (PCSA) stock is trading at $0.12, marking a fall of -14.91% from last night’s close. At ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.